The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection (Q37880009)

24 August 2017

1 reference

title

The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection (English)

1 reference

24 August 2017

main subject

Legionella pneumophila

1 reference

inferred from title

Mycoplasma pneumoniae

object named as

Mycoplasma pneumoniae

1 reference

Chlamydia pneumoniae

1 reference

1

File TM Jr

1 reference

24 August 2017

2

Tan JS

1 reference

24 August 2017

3

Plouffe JF

1 reference

24 August 2017

publication date

1 September 1998

1 reference

Infectious Disease Clinics of North America

24 August 2017

published in

1 reference

24 August 2017

volume

12

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

569-92, vii

1 reference

Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Prevalence of pneumonia due to Legionella pneumophila and Mycoplasma pneumoniae in a population admitted to a department of internal medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Oropharyngeal colonization with Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Detection of Chlamydia pneumoniae by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Efficacy of clarithromycin against Mycoplasma pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Infection with Chlamydia pneumoniae in Brooklyn

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Mycoplasma pneumoniae as a cofactor in severe respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : A FILTERABLE AGENT TRANSMISSIBLE TO COTTON RATS, HAMSTERS, AND CHICK EMBRYOS.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Sporadic legionellosis in the United States: the first thousand cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

The molecular ecology of legionellae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Diagnostic methods for intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Persistent infection with Chlamydia pneumoniae following acute respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

In vitro activities of five quinolones against Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Comparative Features of Pneumococcal, Mycoplasmal, and Legionnaires' Disease Pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Sporadic Legionnaires' disease: clinical observations on 87 nosocomial and community-acquired cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Community outbreak of Legionnaires' disease: an investigation confirming the potential for cooling towers to transmit Legionella species

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Chlamydia pneumoniae (TWAR).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Serological investigation of pneumonia as it presents to the physician's office

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Atypical pathogen pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Bronchiolitis Obliterans Organizing Pneumonia Associated with AcuteMycoplasma pneumoniaeInfection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Severe community-acquired pneumonia, shock and multiorgan dysfunction syndrome caused by Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Pneumonia associated with the TWAR strain of Chlamydia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. CBPIS Study Group. Community-based Pneumonia Incidence Study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Rote of the quinolones in the treatment of legionellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Mode of transmission of Legionella pneumophila. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Community-acquired pneumonia: impact of immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

The protean manifestations of mycoplasma pneumoniae infection in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Chlamydia pneumoniae. New diagnostic tools for detection of a common pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Treatment of Legionnaires' disease. Current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Comparison of Antibiotics in the Treatment of Mycoplasmal Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Shedding ofMycoplasma pneumoniaeafter Tetracycline and Erythromycin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

1 reference

7 January 2021

Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Bacterial or nonbacterial pneumonia: accuracy of radiographic diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970199-9

7 January 2021

10.1016/S0891-5520(05)70199-9

Identifiers

DOI

1 reference

release_tu5bzgtu5jh5pizy5cfjw7wrxq

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tu5bzgtu5jh5pizy5cfjw7wrxq

24 November 2022

mapped directly with Wikidata item

1 reference